Year |
Citation |
Score |
2023 |
Amin G, Booz GW, Zouein FA. Proteinopathy: Shared Feature between the Heart and Brain in Alzheimer's Disease. Journal of Cardiovascular Pharmacology. PMID 37890458 DOI: 10.1097/FJC.0000000000001501 |
0.596 |
|
2023 |
Mekary W, Fares S, Abdulhai F, Massoud G, Refaat M, Mericskay M, Booz GW, Zouein FA. Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients. Heliyon. 9: e19373. PMID 37662725 DOI: 10.1016/j.heliyon.2023.e19373 |
0.632 |
|
2023 |
Kaplan A, Lakkis B, El-Samadi L, Karaayvaz EB, Booz GW, Zouein FA. Cooling Down Inflammation in the Cardiovascular System via the Nicotinic Acetylcholine Receptor. Journal of Cardiovascular Pharmacology. PMID 37539950 DOI: 10.1097/FJC.0000000000001455 |
0.673 |
|
2023 |
Altara R, Booz GW. Central role for BRAF in cardiac hypertrophy: rethinking the pathological-physiological divide. Clinical Science (London, England : 1979). 137: 143-148. PMID 36651286 DOI: 10.1042/CS20220776 |
0.389 |
|
2023 |
Massoud GP, Hazimeh DH, Amin G, Mekary W, Khabsa J, Araji T, Fares S, Mericskay M, Booz GW, Zouein FA. Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review. European Journal of Pharmacology. 941: 175501. PMID 36641102 DOI: 10.1016/j.ejphar.2023.175501 |
0.544 |
|
2022 |
Habeichi N, Ghali R, Mroueh A, Kaplan A, Tannous C, Jurjus A, Amin G, Mericskay M, Booz GW, El-Yazbi A, Zouein FA. Sexual Dimorphism in Acute Myocardial Infarction-Induced Acute Kidney Injury: Cardio-Renal Deteriorating Effects of Ovariectomy in Premenopausal Female Mice. Clinical Science (London, England : 1979). PMID 36519413 DOI: 10.1042/CS20220513 |
0.586 |
|
2022 |
Amin G, Massoud G, Fares S, Booz GW, Zouein FA. Colchicine and acute coronary syndromes: a new trick for an old drug? Journal of Cardiovascular Pharmacology. PMID 35998032 DOI: 10.1097/FJC.0000000000001358 |
0.545 |
|
2022 |
Smith AN, Altara R, Amin G, Habeichi NJ, Thomas DG, Jun S, Kaplan A, Booz GW, Zouein FA. Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure With Preserved Ejection Fraction: A Tale of Mice, Rats, and Cats. Journal of the American Heart Association. 11: e026071. PMID 35904190 DOI: 10.1161/JAHA.122.026071 |
0.658 |
|
2022 |
Kaplan A, Abidi E, Diab R, Ghali R, Al-Awassi H, Booz GW, Zouein FA. Sex differences in cardiac remodeling post myocardial infarction with acute cigarette smoking. Biology of Sex Differences. 13: 36. PMID 35799275 DOI: 10.1186/s13293-022-00446-y |
0.608 |
|
2022 |
Booz GW, Altara R, Zouein FA. Editorial: Immunomodulatory Approaches in Cardiovascular Diseases. Frontiers in Cardiovascular Medicine. 9: 873452. PMID 35433872 DOI: 10.3389/fcvm.2022.873452 |
0.564 |
|
2022 |
Tombolesi N, Altara R, da Silva GJJ, Tannous C, Zouein FA, Stensløkken KO, Morresi A, Paolantoni M, Booz GW, Cataliotti A, Sassi P. Early cardiac-chamber-specific fingerprints in heart failure with preserved ejection fraction detected by FTIR and Raman spectroscopic techniques. Scientific Reports. 12: 3440. PMID 35236899 DOI: 10.1038/s41598-022-07390-2 |
0.645 |
|
2022 |
Kaplan A, Amin G, Abidi E, Altara R, Booz GW, Zouein FA. Role of ranolazine in heart failure: From cellular to clinic perspective. European Journal of Pharmacology. 919: 174787. PMID 35114190 DOI: 10.1016/j.ejphar.2022.174787 |
0.676 |
|
2021 |
Habeichi NJ, Tannous C, Yabluchanskiy A, Altara R, Mericskay M, Booz GW, Zouein FA. Insights into the modulation of the interferon response and NAD in the context of COVID-19. International Reviews of Immunology. 1-11. PMID 34378474 DOI: 10.1080/08830185.2021.1961768 |
0.58 |
|
2021 |
Booz GW, Massoud GP, Altara R, Zouein FA. Unravelling the impact of intrauterine growth restriction on heart development: insights into mitochondria and sexual dimorphism from a non-hominoid primate. Clinical Science (London, England : 1979). 135: 1767-1772. PMID 34313297 DOI: 10.1042/CS20210524 |
0.628 |
|
2021 |
da Silva GJJ, Altara R, Booz GW, Cataliotti A. Atrial Natriuretic Peptide: A Novel Therapeutic Factor for Cardiovascular Diseases. Frontiers in Physiology. 12: 691407. PMID 34305645 DOI: 10.3389/fphys.2021.691407 |
0.3 |
|
2021 |
Kaplan A, Altara R, Manca M, Gunes HM, Cataliotti A, Booz GW, Zouein FA. Distorted assessment of left atrial size by echocardiography in patients with increased aortic root diameter. The Egyptian Heart Journal : (Ehj) : Official Bulletin of the Egyptian Society of Cardiology. 73: 55. PMID 34173898 DOI: 10.1186/s43044-021-00177-2 |
0.56 |
|
2021 |
Zouein FA, Altara R, Massoud GP, Booz GW. The Angiotensin II Type 1 (AT1) Receptor and Cardiac Hypertrophy: Did we have it wrong all along? Journal of Cardiovascular Pharmacology. PMID 33657051 DOI: 10.1097/FJC.0000000000000999 |
0.663 |
|
2020 |
Booz GW, Zouein FA. Science unites a troubled world: Lessons from the pandemic. European Journal of Pharmacology. 173696. PMID 33130278 DOI: 10.1016/j.ejphar.2020.173696 |
0.552 |
|
2020 |
Booz GW, Altara R, Eid AH, Wehbe Z, Fares S, Zaraket H, Habeichi NJ, Zouein FA. Macrophage responses associated with COVID-19: A pharmacological perspective. European Journal of Pharmacology. 173547. PMID 32919938 DOI: 10.1016/J.Ejphar.2020.173547 |
0.628 |
|
2020 |
Tannous C, Booz GW, Altara R, Muhieddine DH, Mericksay M, Refaat M, Zouein FA. Nicotinamide Adenine Dinucleotide: Biosynthesis, Consumption, and Therapeutic Role in Cardiac Diseases. Acta Physiologica (Oxford, England). PMID 32853469 DOI: 10.1111/Apha.13551 |
0.685 |
|
2020 |
Noureddine FY, Altara R, Fan F, Yabluchanskiy A, Booz GW, Zouein FA. Impact of the Renin-Angiotensin System on the Endothelium in Vascular Dementia: Unresolved Issues and Future Perspectives. International Journal of Molecular Sciences. 21. PMID 32560034 DOI: 10.3390/Ijms21124268 |
0.627 |
|
2020 |
Altara R, Zouein FA, Booz GW. Untangling the Interplay Between Mitochondrial Fission and NF-κB Signaling in Endothelial Inflammation. Hypertension (Dallas, Tex. : 1979). 76: 23-25. PMID 32520615 DOI: 10.1161/Hypertensionaha.120.14854 |
0.617 |
|
2020 |
Habeichi NJ, Mroueh A, Kaplan A, Ghali R, Al-Awassi H, Tannous C, Husari A, Jurjus A, Altara R, Booz GW, El-Yazbi A, Zouein FA. Sex-based differences in myocardial infarction-induced kidney damage following cigarette smoking exposure: more renal protection in premenopausal female mice. Bioscience Reports. 40. PMID 32519752 DOI: 10.1042/Bsr20193229 |
0.622 |
|
2020 |
Kurdi M, Pollesello P, Booz GW. Levosimendan Comes of Age: Twenty Years of Clinical Use. Journal of Cardiovascular Pharmacology. PMID 32433361 DOI: 10.1097/Fjc.0000000000000850 |
0.361 |
|
2020 |
Ghali R, Habeichi N, Kaplan A, Tannous C, Abidi E, Bekdash A, Farhat R, Itani H, Jurjus A, Booz GW, Mallat Z, Zouein FA. IL-33 Induces Type-2-Cytokine Phenotype but Exacerbates Cardiac Remodeling Post-Myocardial Infarction with Eosinophil Recruitment, Worsened Systolic Dysfunction, and Ventricular Wall Rupture. Clinical Science (London, England : 1979). PMID 32432676 DOI: 10.1042/Cs20200402 |
0.682 |
|
2020 |
Zouein FA, Booz GW. Targeting mitochondria to protect the heart: a matter of balance? Clinical Science (London, England : 1979). 134: 885-888. PMID 32286622 DOI: 10.1042/Cs20200236 |
0.632 |
|
2020 |
Altara R, da Silva GJJ, Frisk M, Spelta F, Zouein FA, Louch WE, Booz GW, Cataliotti A. Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA12014. PMID 32200677 DOI: 10.1161/Hypertensionaha.120.14704 |
0.643 |
|
2020 |
Lukowski R, Booz GW. Deciphering the dynamics and therapeutic potential of the cardiac cGMP cascade: An update on where we are and what we need to know. Journal of Cardiovascular Pharmacology. PMID 32106180 DOI: 10.1097/Fjc.0000000000000814 |
0.362 |
|
2020 |
Kaplan A, Abidi E, Habeichi NJ, Ghali R, Alawasi H, Fakih C, Zibara K, Kobeissy F, Husari A, Booz GW, Zouein FA. Gender-biased kidney damage in mice following exposure to tobacco cigarette smoke: More protection in premenopausal females. Physiological Reports. 8: e14339. PMID 31981316 DOI: 10.14814/Phy2.14339 |
0.614 |
|
2019 |
Bejjani AT, Saab SA, Muhieddine DH, Habeichi NJ, Booz GW, Zouein FA. Spatiotemporal Dynamics of Immune Cells in Early Left Venticular Remodeling after Acute Myocardial Infarction in Mice. Journal of Cardiovascular Pharmacology. PMID 31764396 DOI: 10.1097/Fjc.0000000000000777 |
0.678 |
|
2019 |
Harhous Z, Booz GW, Ovize M, Bidaux G, Kurdi M. An Update on the Multifaceted Roles of STAT3 in the Heart. Frontiers in Cardiovascular Medicine. 6: 150. PMID 31709266 DOI: 10.3389/Fcvm.2019.00150 |
0.446 |
|
2019 |
Abbate A, Booz GW. Cardiovascular Pharmacology of the NLRP3 Inflammasome. Journal of Cardiovascular Pharmacology. 74: 173-174. PMID 31498192 DOI: 10.1097/Fjc.0000000000000725 |
0.304 |
|
2019 |
Zouein FA, Booz GW, Altara R. STAT3 and Endothelial Cell-Cardiomyocyte Dialog in Cardiac Remodeling. Frontiers in Cardiovascular Medicine. 6: 50. PMID 31069236 DOI: 10.3389/Fcvm.2019.00050 |
0.696 |
|
2019 |
Harhous Z, Badawi S, Bona NG, Pillot B, Augeul L, Paillard M, Booz GW, Canet-Soulas E, Ovize M, Kurdi M, Bidaux G. Critical appraisal of STAT3 pattern in adult cardiomyocytes. Journal of Molecular and Cellular Cardiology. 131: 91-100. PMID 31022374 DOI: 10.1016/J.Yjmcc.2019.04.021 |
0.386 |
|
2019 |
Altara R, da Silva G, Frisk M, Norden E, Spelta F, Espe E, Sjaastad I, Zouein F, Louch W, Booz G, Cataliotti A. CARDIORENAL PROTECTIVE EFFECTS OF PRO-ATRIAL-NATRIURETIC-PEPTIDE (31–67) INDEPENDENT OF BLOOD PRESSURE Journal of Hypertension. 37: e27. DOI: 10.1097/01.Hjh.0000570632.35593.C6 |
0.637 |
|
2018 |
Kurdi M, Zgheib C, Booz GW. Recent Developments on the Crosstalk Between STAT3 and Inflammation in Heart Function and Disease. Frontiers in Immunology. 9: 3029. PMID 30619368 DOI: 10.3389/Fimmu.2018.03029 |
0.732 |
|
2018 |
Ghali R, Altara R, Louch WE, Cataliotti A, Mallat Z, Kaplan A, Zouein FA, Booz GW. IL-33 (Interleukin 33)/sST2 (Soluble Suppression of Tumorigenicity 2) Axis in Hypertension and Heart Failure. Hypertension (Dallas, Tex. : 1979). 72: 818-828. PMID 30354724 DOI: 10.1161/Hypertensionaha.118.11157 |
0.663 |
|
2018 |
Kaplan A, Yabluchanskiy A, Ghali R, Altara R, Booz GW, Zouein FA. Cerebral Blood Flow Alteration Following Acute Myocardial Infarction in Mice. Bioscience Reports. PMID 30061176 DOI: 10.1042/Bsr20180382 |
0.619 |
|
2018 |
Altara R, Ghali R, Mallat Z, Cataliotti A, Booz GW, Zouein FA. Conflicting Vascular and Metabolic Impact of the IL-33/sST2 Axis. Cardiovascular Research. PMID 29982301 DOI: 10.1093/Cvr/Cvy166 |
0.605 |
|
2018 |
Zhang C, Booz GW, Yu Q, He X, Wang S, Fan F. Conflicting roles of 20-HETE in hypertension and renal end organ damage. European Journal of Pharmacology. PMID 29886242 DOI: 10.1016/J.Ejphar.2018.06.010 |
0.317 |
|
2018 |
Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, Scalia R, Eguchi S. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. Physiological Reviews. 98: 1627-1738. PMID 29873596 DOI: 10.1152/Physrev.00038.2017 |
0.349 |
|
2018 |
Altara R, Zouein FA, Brandão RD, Bajestani SN, Cataliotti A, Booz GW.
Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction. Frontiers in Cardiovascular Medicine. 5: 11. PMID 29556499 DOI: 10.3389/Fcvm.2018.00011 |
0.681 |
|
2018 |
Lv W, Booz GW, Fan F, Wang Y, Roman RJ. Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies. Frontiers in Physiology. 9: 105. PMID 29503620 DOI: 10.3389/Fphys.2018.00105 |
0.312 |
|
2018 |
Kaplan A, Abidi E, El-Yazbi A, Eid A, Booz GW, Zouein FA. Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects. Heart Failure Reviews. PMID 29322280 DOI: 10.1007/S10741-017-9665-9 |
0.668 |
|
2017 |
Lv W, Booz GW, Wang Y, Fan F, Roman RJ. Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. European Journal of Pharmacology. 820: 65-76. PMID 29229532 DOI: 10.1016/J.Ejphar.2017.12.016 |
0.319 |
|
2017 |
Kaplan A, Abidi E, Ghali R, Booz GW, Kobeissy F, Zouein FA. Functional, Cellular, and Molecular Remodeling of the Heart under Influence of Oxidative Cigarette Tobacco Smoke. Oxidative Medicine and Cellular Longevity. 2017: 3759186. PMID 28808498 DOI: 10.1155/2017/3759186 |
0.662 |
|
2016 |
Kaplan A, Altara R, Eid A, Booz GW, Zouein FA. Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart. Journal of Cardiovascular Pharmacology. 68: 401-413. PMID 27941502 DOI: 10.1097/Fjc.0000000000000436 |
0.699 |
|
2016 |
Altara R, Harmancey R, Didion SP, Booz GW, Zouein FA. Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension. Frontiers in Pharmacology. 7: 436. PMID 27899891 DOI: 10.3389/Fphar.2016.00436 |
0.687 |
|
2016 |
Altara R, Mallat Z, Booz GW, Zouein FA. The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart. Journal of Immunology Research. 2016: 4396368. PMID 27795961 DOI: 10.1155/2016/4396368 |
0.693 |
|
2016 |
Altara R, Didion SP, Booz GW. Conflicting mechanisms of AT2 cardioprotection revealed. Cardiovascular Research. 112: 426-8. PMID 27659501 DOI: 10.1093/Cvr/Cvw199 |
0.351 |
|
2016 |
Altara R, Booz GW. Deleting Vascular ADAM17 Sheds New Light on Hypertensive Cardiac Hypertrophy. Hypertension. PMID 27480838 DOI: 10.1161/Hypertensionaha.116.07715 |
0.374 |
|
2016 |
Altara R, Manca M, Hessel MH, Gu Y, van Vark LC, Akkerhuis KM, Staessen JA, Struijker-Boudier HA, Booz GW, Blankesteijn WM. CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study. Journal of Cardiovascular Translational Research. PMID 27271043 DOI: 10.1007/s12265-016-9703-3 |
0.312 |
|
2016 |
Altara R, Manca M, Brandão RD, Zeidan A, Booz GW, Zouein FA. Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases. Clinical Science (London, England : 1979). 130: 463-78. PMID 26888559 DOI: 10.1042/Cs20150666 |
0.665 |
|
2015 |
Zouein FA, Altara R, Chen Q, Lesnefsky EJ, Kurdi M, Booz GW. Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues. Frontiers in Cardiovascular Medicine. 2: 36. PMID 26664907 DOI: 10.3389/Fcvm.2015.00036 |
0.707 |
|
2015 |
Altara R, Manca M, Sabra R, Eid AA, Booz GW, Zouein FA. Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. Heart Failure Reviews. PMID 26498937 DOI: 10.1007/S10741-015-9513-8 |
0.644 |
|
2015 |
Zeng H, Vaka VR, He X, Booz GW, Chen JX. High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. Journal of Cellular and Molecular Medicine. PMID 25782072 DOI: 10.1111/Jcmm.12556 |
0.43 |
|
2014 |
Zouein FA, Kurdi M, Booz GW, Fuseler JW. Applying fractal dimension and image analysis to quantify fibrotic collagen deposition and organization in the normal and hypertensive heart. Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 20: 1134-44. PMID 25410603 DOI: 10.1017/S1431927614001044 |
0.673 |
|
2014 |
Kurdi M, Booz GW. Carvedilol protects the infarcted heart by upregulating miR-133: first evidence that disease state affects β-adrenergic arrestin-biased signaling? Journal of Molecular and Cellular Cardiology. 76: 12-4. PMID 25128784 DOI: 10.1016/J.Yjmcc.2014.08.004 |
0.323 |
|
2014 |
Zouein FA, Duhé RJ, Arany I, Shirey K, Hosler JP, Liu H, Saad I, Kurdi M, Booz GW. Loss of STAT3 in mouse embryonic fibroblasts reveals its Janus-like actions on mitochondrial function and cell viability. Cytokine. 66: 7-16. PMID 24548419 DOI: 10.1016/J.Cyto.2013.12.006 |
0.647 |
|
2013 |
Zouein FA, Kurdi M, Booz GW. Dancing rhinos in stilettos: The amazing saga of the genomic and nongenomic actions of STAT3 in the heart. Jak-Stat. 2: e24352. PMID 24069556 DOI: 10.4161/jkst.24352 |
0.686 |
|
2013 |
Zouein FA, Booz GW. AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling. F1000prime Reports. 5: 27. PMID 23967378 DOI: 10.12703/P5-27 |
0.697 |
|
2013 |
Zouein FA, Kurdi M, Booz GW. HSPA12B and repairing the heart: beauty in simplicity. Cardiovascular Research. 99: 587-9. PMID 23867633 DOI: 10.1093/Cvr/Cvt185 |
0.663 |
|
2013 |
Werner T, Dombrowski SM, Zgheib C, Zouein FA, Keen HL, Kurdi M, Booz GW. Elucidating functional context within microarray data by integrated transcription factor-focused gene-interaction and regulatory network analysis. European Cytokine Network. 24: 75-90. PMID 23822978 DOI: 10.1684/Ecn.2013.0336 |
0.728 |
|
2013 |
Zouein FA, de Castro Brás LE, da Costa DV, Lindsey ML, Kurdi M, Booz GW. Heart failure with preserved ejection fraction: emerging drug strategies. Journal of Cardiovascular Pharmacology. 62: 13-21. PMID 23714774 DOI: 10.1097/Fjc.0B013E31829A4E61 |
0.701 |
|
2013 |
Zouein FA, Kurdi M, Booz GW. LIF and the heart: just another brick in the wall? European Cytokine Network. 24: 11-9. PMID 23661360 DOI: 10.1684/Ecn.2013.0335 |
0.73 |
|
2013 |
Zouein FA, Zgheib C, Hamza S, Fuseler JW, Hall JE, Soljancic A, Lopez-Ruiz A, Kurdi M, Booz GW. Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hypertension Research : Official Journal of the Japanese Society of Hypertension. 36: 496-503. PMID 23364341 DOI: 10.1038/Hr.2012.223 |
0.785 |
|
2013 |
Fuseler J, Zouein F, Kurdi M, Booz G. Fractal and Image Analysis of Collagen Fibrosis in Hypertensive Induced Myocardial Remodeling in Mouse Hearts Lacking STAT3 Protection Microscopy and Microanalysis. 19: 242-243. DOI: 10.1017/S1431927613003206 |
0.675 |
|
2012 |
Zgheib C, Zouein FA, Kurdi M, Booz GW. Differential STAT3 signaling in the heart: Impact of concurrent signals and oxidative stress. Jak-Stat. 1: 101-10. PMID 23904970 DOI: 10.4161/jkst.19776 |
0.758 |
|
2012 |
Zgheib C, Zouein FA, Kurdi M, Booz GW. Chronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function. European Cytokine Network. 23: 191-7. PMID 23291613 DOI: 10.1684/Ecn.2012.0319 |
0.795 |
|
2012 |
Kurdi M, Sivakumaran V, Duhé RJ, Aon MA, Paolocci N, Booz GW. Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes. The International Journal of Biochemistry & Cell Biology. 44: 2106-15. PMID 22939972 DOI: 10.1016/J.Biocel.2012.08.016 |
0.425 |
|
2012 |
Zgheib C, Kurdi M, Zouein FA, Gunter BW, Stanley BA, Zgheib J, Romero DG, King SB, Paolocci N, Booz GW. Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitive. Plos One. 7: e43313. PMID 22905257 DOI: 10.1371/Journal.Pone.0043313 |
0.778 |
|
2012 |
Zouein FA, Zgheib C, Liechty KW, Booz GW. Post-infarct biomaterials, left ventricular remodeling, and heart failure: is good good enough? Congestive Heart Failure (Greenwich, Conn.). 18: 284-90. PMID 22612796 DOI: 10.1111/J.1751-7133.2012.00298.X |
0.793 |
|
2012 |
Alturkmani HJ, Zgheib C, Zouein FA, Alshaaer NE, Kurdi M, Booz GW. Selenate enhances STAT3 transcriptional activity in endothelial cells: differential actions of selenate and selenite on LIF cytokine signaling and cell viability. Journal of Inorganic Biochemistry. 109: 9-15. PMID 22366233 DOI: 10.1016/J.Jinorgbio.2012.01.008 |
0.761 |
|
2012 |
Arany I, Reed DK, Grifoni SC, Chandrashekar K, Booz GW, Juncos LA. A novel U-STAT3-dependent mechanism mediates the deleterious effects of chronic nicotine exposure on renal injury. American Journal of Physiology. Renal Physiology. 302: F722-9. PMID 22169004 DOI: 10.1152/Ajprenal.00338.2011 |
0.3 |
|
2012 |
Zgheib C, Zouein FA, Chidiac R, Kurdi M, Booz GW. Calyculin A reveals serine/threonine phosphatase protein phosphatase 1 as a regulatory nodal point in canonical signal transducer and activator of transcription 3 signaling of human microvascular endothelial cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 32: 87-94. PMID 22142222 DOI: 10.1089/Jir.2011.0059 |
0.76 |
|
2011 |
Kurdi M, Booz GW. Focus on mitochondria dysfunction and dysregulation in heart failure: towards new therapeutic strategies to improve heart function. Congestive Heart Failure (Greenwich, Conn.). 17: 255-6. PMID 22103916 DOI: 10.1111/J.1751-7133.2011.00269.X |
0.426 |
|
2011 |
Zouein FA, Duhé RJ, Booz GW. JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth. Growth Factors (Chur, Switzerland). 29: 245-52. PMID 21892841 DOI: 10.3109/08977194.2011.614949 |
0.652 |
|
2011 |
Kurdi M, Booz GW. New take on the role of angiotensin II in cardiac hypertrophy and fibrosis. Hypertension. 57: 1034-8. PMID 21502563 DOI: 10.1161/Hypertensionaha.111.172700 |
0.418 |
|
2011 |
Kurdi M, Booz GW. Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC. Journal of Molecular and Cellular Cardiology. 50: 964-71. PMID 21320507 DOI: 10.1016/J.Yjmcc.2011.02.004 |
0.417 |
|
2011 |
Booz GW. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radical Biology & Medicine. 51: 1054-61. PMID 21238581 DOI: 10.1016/J.Freeradbiomed.2011.01.007 |
0.306 |
|
2010 |
Kurdi M, Booz GW. Deciphering STAT3 signaling in the heart: plasticity and vascular inflammation. Congestive Heart Failure (Greenwich, Conn.). 16: 234-8. PMID 20887622 DOI: 10.1111/J.1751-7133.2010.00175.X |
0.446 |
|
2010 |
Booz GW. Novel drugs targeting hypertension revisited. Journal of Cardiovascular Pharmacology. 56: 213-4. PMID 20844362 DOI: 10.1097/Fjc.0B013E3181F0D63F |
0.332 |
|
2010 |
Kurdi M, Chidiac R, Hoemann C, Zouein F, Zgheib C, Booz GW. Hydrogels as a platform for stem cell delivery to the heart. Congestive Heart Failure (Greenwich, Conn.). 16: 132-5. PMID 20557335 DOI: 10.1111/J.1751-7133.2010.00145.X |
0.741 |
|
2009 |
Kurdi M, Booz GW. JAK redux: a second look at the regulation and role of JAKs in the heart. American Journal of Physiology. Heart and Circulatory Physiology. 297: H1545-56. PMID 19717737 DOI: 10.1152/Ajpheart.00032.2009 |
0.435 |
|
2008 |
Kurdi M, Booz GW. Growing hearts by the bushel. Congestive Heart Failure (Greenwich, Conn.). 14: 95-6. PMID 18401219 DOI: 10.1111/J.1751-7133.2008.08332.X |
0.416 |
|
2007 |
Kurdi M, Booz GW. G-CSF-based stem cell therapy for the heart--unresolved issues part B: Stem cells, engraftment, transdifferentiation, and bioengineering. Congestive Heart Failure (Greenwich, Conn.). 13: 347-51. PMID 18046094 DOI: 10.1111/J.1527-5299.2007.07112.X |
0.368 |
|
2007 |
Kurdi M, Booz GW. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling. Journal of Cardiovascular Pharmacology. 50: 126-41. PMID 17703129 DOI: 10.1097/Fjc.0B013E318068Dd49 |
0.384 |
|
2007 |
Kurdi M, Booz GW. G-CSF-based stem cell therapy for the heart-unresolved issues part A: paracrine actions, mobilization, and delivery. Congestive Heart Failure (Greenwich, Conn.). 13: 221-7. PMID 17673875 DOI: 10.1111/J.1527-5299.2007.07111.X |
0.355 |
|
2007 |
Booz GW. PARP inhibitors and heart failure--translational medicine caught in the act. Congestive Heart Failure (Greenwich, Conn.). 13: 105-12. PMID 17392615 DOI: 10.1111/J.1527-5299.2007.06595.X |
0.379 |
|
2007 |
Kurdi M, Booz GW. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS. Journal of Cellular Physiology. 212: 424-31. PMID 17385713 DOI: 10.1002/Jcp.21033 |
0.349 |
|
2007 |
Kurdi M, Bowers MC, Dado J, Booz GW. Parthenolide induces a distinct pattern of oxidative stress in cardiac myocytes. Free Radical Biology & Medicine. 42: 474-81. PMID 17275679 DOI: 10.1016/J.Freeradbiomed.2006.11.012 |
0.386 |
|
2007 |
Kurdi M, Booz GW. Oxidative stress blocks activation of JAK–STAT signaling in cardiac myocytes Journal of Molecular and Cellular Cardiology. 42: S50. DOI: 10.1016/J.Yjmcc.2007.03.142 |
0.358 |
|
2006 |
Booz GW. Impact of T lymphocytes on cardiac remodeling in hypertension: more questions than answers. Hypertension. 48: 31-2. PMID 16735641 DOI: 10.1161/01.Hyp.0000227248.81004.00 |
0.419 |
|
2005 |
Booz GW. Growing old, angiotensin II, cardiac hypertrophy, and death: making the connection with p66Shc. Hypertension. 46: 259-60. PMID 15998703 DOI: 10.1161/01.Hyp.0000174987.36538.D5 |
0.382 |
|
2005 |
Kurdi M, De Mello WC, Booz GW. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. The International Journal of Biochemistry & Cell Biology. 37: 1357-67. PMID 15833268 DOI: 10.1016/J.Biocel.2005.01.012 |
0.355 |
|
2005 |
Booz GW. Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system. Hypertension. 45: 341-6. PMID 15710777 DOI: 10.1161/01.Hyp.0000156878.17006.02 |
0.469 |
|
2004 |
Baker KM, Chernin MI, Schreiber T, Sanghi S, Haiderzaidi S, Booz GW, Dostal DE, Kumar R. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regulatory Peptides. 120: 5-13. PMID 15177915 DOI: 10.1016/J.Regpep.2004.04.004 |
0.367 |
|
2004 |
Booz GW. Cardiac angiotensin AT2 receptor: what exactly does it do? Hypertension. 43: 1162-3. PMID 15117917 DOI: 10.1161/01.Hyp.0000128531.39964.C0 |
0.393 |
|
2004 |
Day JN, Booz GW. Molecular mechanisms of IL-6-related-cytokine STAT3 regulation in cardiac myocytes Journal of Cardiac Failure. 10: S50. DOI: 10.1016/J.Cardfail.2004.06.118 |
0.359 |
|
2003 |
Booz GW, Day JN, Baker KM. Angiotensin II effects on STAT3 phosphorylation in cardiomyocytes: evidence for Erk-dependent Tyr705 dephosphorylation. Basic Research in Cardiology. 98: 33-8. PMID 12494267 DOI: 10.1007/S00395-003-0387-X |
0.307 |
|
2003 |
Booz GW, Day JN, Baker KM. Erratum to “Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure” [J Mol Cell Cardiol 2002;34:1443–1453] Journal of Molecular and Cellular Cardiology. 35: 225. DOI: 10.1016/S0022-2828(02)00308-5 |
0.332 |
|
2002 |
Booz GW, Day JN, Speth R, Baker KM. Cytokine G-protein signaling crosstalk in cardiomyocytes: attenuation of Jak-STAT activation by endothelin-1. Molecular and Cellular Biochemistry. 240: 39-46. PMID 12487370 DOI: 10.1023/A:1020648425895 |
0.402 |
|
2002 |
Booz GW, Day JN, Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. Journal of Molecular and Cellular Cardiology. 34: 1443-53. PMID 12431443 DOI: 10.1006/Jmcc.2002.2076 |
0.49 |
|
2000 |
Dostal DE, Booz GW, Baker KM. Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and beta-adrenergic stimulation. Basic Research in Cardiology. 95: 485-90. PMID 11192370 DOI: 10.1007/S003950070025 |
0.351 |
|
2000 |
Fukuzawa J, Booz GW, Hunt RA, Shimizu N, Karoor V, Baker KM, Dostal DE. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy. Hypertension (Dallas, Tex. : 1979). 35: 1191-6. PMID 10856262 DOI: 10.1161/01.Hyp.35.6.1191 |
0.435 |
|
1999 |
Booz GW, Dostal DE, Baker KM. Paracrine actions of cardiac fibroblasts on cardiomyocytes: implications for the cardiac renin-angiotensin system. The American Journal of Cardiology. 83: 44H-47H. PMID 10750586 DOI: 10.1016/S0002-9149(99)00257-X |
0.413 |
|
1999 |
Booz GW, Carl LL, Baker KM. Amplification of angiotensin II signaling in cardiac myocytes by adenovirus-mediated overexpression of the AT1 receptor Annals of the New York Academy of Sciences. 874: 20-26. PMID 10415517 DOI: 10.1111/J.1749-6632.1999.Tb09221.X |
0.359 |
|
1998 |
Booz GW, Baker KM. Actions of Angiotensin II on isolated cardiac myocytes Heart Failure Reviews. 3: 125-130. DOI: 10.1023/A:1009788013090 |
0.413 |
|
1996 |
Booz GW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin II- induced cardiomyocyte hypertrophy Hypertension. 28: 635-640. PMID 8843890 DOI: 10.1161/01.Hyp.28.4.635 |
0.301 |
|
1996 |
Dostal DE, Booz GW, Baker KM. Angiotensin II signalling pathways in cardiac fibroblasts: Conventional versus novel mechanisms in mediating cardiac growth and function Molecular and Cellular Biochemistry. 157: 15-21. PMID 8739224 DOI: 10.1007/Bf00227876 |
0.419 |
|
1995 |
Booz GW, Baker KM. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts Cardiovascular Research. 30: 537-543. PMID 8575002 DOI: 10.1016/S0008-6363(96)88507-5 |
0.433 |
|
1995 |
Booz GW, Baker KM. Protein kinase C in angiotensin II signalling in neonatal rat cardiac fibroblasts. Role in the mitogenic response Annals of the New York Academy of Sciences. 752: 158-167. PMID 7755255 DOI: 10.1111/J.1749-6632.1995.Tb17419.X |
0.334 |
|
1994 |
Booz GW, Dostal DE, Singer HA, Baker KM. Involvement of protein kinase C and Ca2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts American Journal of Physiology - Cell Physiology. 267. PMID 7977694 DOI: 10.1152/Ajpcell.1994.267.5.C1308 |
0.307 |
|
1994 |
Booz GW, Taher MM, Baker KM, Singer HA. Angiotensin II induces phosphatidic acid formation in neonatal rat cardiac fibroblasts: Evaluation of the roles of phospholipases C and D Molecular and Cellular Biochemistry. 141: 135-143. PMID 7891671 DOI: 10.1007/Bf00926177 |
0.313 |
|
1993 |
Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts Circulation Research. 72: 1245-1254. PMID 8495553 DOI: 10.1161/01.Res.72.6.1245 |
0.343 |
|
1992 |
Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system Annual Review of Physiology. 54: 227-241. PMID 1562174 DOI: 10.1146/Annurev.Ph.54.030192.001303 |
0.398 |
|
Show low-probability matches. |